Acadian Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,200
| Closed | -$196K | – | 2127 |
|
|
2024
Q3 | $196K | Buy |
+10,200
| New | +$196K | ﹤0.01% | 1373 |
|
|
2020
Q2 | – | Sell |
-12,301
| Closed | -$135K | – | 2331 |
|
|
2020
Q1 | $135K | Buy |
12,301
+2,440
| +25% | +$26.8K | ﹤0.01% | 1288 |
|
|
2019
Q4 | $87K | Sell |
9,861
-19,203
| -66% | -$169K | ﹤0.01% | 1506 |
|
|
2019
Q3 | $217K | Buy |
29,064
+8,559
| +42% | +$63.9K | ﹤0.01% | 1302 |
|
|
2019
Q2 | $191K | Buy |
+20,505
| New | +$191K | ﹤0.01% | 1236 |
|
|
2018
Q3 | – | Sell |
-2,963
| Closed | -$21K | – | 1782 |
|
|
2018
Q2 | $21K | Buy |
+2,963
| New | +$21K | ﹤0.01% | 1524 |
|